• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to (2,3-dimethyl-2H-indazol-5-yl)methanamine (CAS No: 1234616-62-6)

Chemical compounds play a pivotal role in the advancement of pharmaceutical research and development, with each molecule holding the potential to revolutionize therapeutic strategies. Among these, (2,3-dimethyl-2H-indazol-5-yl)methanamine, identified by its CAS number 1234616-62-6, has emerged as a compound of significant interest due to its unique structural properties and promising biological activities. This introduction delves into the compound's characteristics, its potential applications, and the latest research findings that underscore its importance in modern medicinal chemistry.

The molecular structure of (2,3-dimethyl-2H-indazol-5-yl)methanamine consists of a fused indazole ring system substituted with two methyl groups at the 2 and 3 positions, a methanamine group at the 5 position, and a central carbon atom linking these functionalities. This intricate arrangement not only contributes to the compound's stability but also enhances its reactivity, making it a versatile scaffold for further chemical modifications. The presence of the indazole core is particularly noteworthy, as it is a motif commonly found in biologically active molecules, including several FDA-approved drugs.

In recent years, there has been growing interest in indazole derivatives due to their diverse pharmacological properties. Studies have shown that compounds containing the indazole scaffold exhibit activities ranging from anti-inflammatory and antimicrobial to antitumor and antiviral effects. The specific substitution pattern in (2,3-dimethyl-2H-indazol-5-yl)methanamine may contribute to its unique pharmacological profile, making it a valuable candidate for further investigation.

One of the most compelling aspects of (2,3-dimethyl-2H-indazol-5-yl)methanamine is its potential as a lead compound for drug discovery. Researchers have been exploring various synthetic routes to modify this molecule, aiming to optimize its biological activity and reduce any potential side effects. The methanamine group at the 5 position provides a handle for further functionalization, allowing chemists to introduce additional moieties that could enhance binding affinity or metabolic stability.

Recent studies have highlighted the compound's role in modulating enzyme activity. Specifically, (2,3-dimethyl-2H-indazol-5-yl)methanamine has been shown to interact with certain enzymes involved in cellular signaling pathways relevant to cancer and inflammation. By understanding these interactions at a molecular level, scientists can design derivatives that are more potent or selective in their target action. This approach aligns with the broader trend in drug development towards precision medicine, where compounds are tailored to individual patient needs.

The synthesis of (2,3-dimethyl-2H-indazol-5-yl)methanamine presents both challenges and opportunities for synthetic chemists. The indazole core requires careful handling during synthesis to preserve its integrity while introducing desired modifications. Advances in synthetic methodologies have made it possible to construct complex molecules like this one with greater efficiency and precision. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in creating the necessary carbon-carbon bonds within the indazole framework.

In addition to its synthetic considerations, the pharmacokinetic properties of (2,3-dimethyl-2H-indazol-5-yl)methanamine are another area of active investigation. Understanding how a compound is absorbed, distributed, metabolized, and excreted is crucial for determining its clinical efficacy and safety profile. Preclinical studies have begun to explore these aspects for this compound, providing valuable insights into its potential as a therapeutic agent.

The future directions for research on (2,3-dimethyl-2H-indazol-5-yl)methanamine are multifaceted. On one hand, scientists aim to refine synthetic strategies to produce larger quantities of the compound for more extensive testing. On the other hand, computational modeling and high-throughput screening techniques are being employed to identify derivatives with enhanced properties. These efforts are part of a larger movement towards data-driven drug discovery, where computational tools complement traditional experimental approaches.

The broader significance of compounds like (2,3-dimethyl-2H-indazol-5-yl)methanamine cannot be overstated. They represent the intersection of organic chemistry, medicinal chemistry, and biochemistry—a convergence that drives innovation in healthcare. As our understanding of biological systems continues to grow, so too does our ability to design molecules that interact with these systems in beneficial ways. (2S)-(1R)-N-(4-fluorobenzyl)-4-methylpyrrolidin-1-carboxamide CAS No: 1078289387 is another example of how structural modifications can lead to novel therapeutics.

In conclusion,(1234616)-62-6 highlights the ongoing efforts in pharmaceutical research aimed at developing new treatments for various diseases. Its unique structure and promising biological activities make it an exciting candidate for further study.(()indazole derivatives continueto be explored as potential therapeutic agents, offering hope for future medical breakthroughs.

• 444731-72-0(2,3-Dimethyl-2H-indazol-6-amine)
• 1060817-08-4(1-(1,5-Dimethyl-1H-indazol-3-yl)methanamine)
• 267413-31-0(1-Methyl-1H-indazole-6-methanamine)
• 1144044-68-7((1-methyl-1H-indazol-4-yl)methanamine)
• 58706-38-0(2H-Indazole, 2,3,7-trimethyl-)
• 1334405-46-7((1-methyl-1H-indazol-4-yl)methanamine hydrochloride)
• 221681-94-3(2,3-Dimethyl-2H-indazol-5-amine)
• 635702-60-2(2,3-Dimethyl-2H-indazol-6-amine hydrochloride)
• 1234615-83-8(2,3-dimethyl-2H-indazole-5-carbaldehyde)
• 50407-18-6(2,3-dimethyl-2H-indazole)